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 2008 Wiley-LissABSTRACT: Simultaneous improvement of solubilization kinetics of main flavolignans
of Silybum marianum extract was obtained cogrinding with two crosslinked polymers:
micronized crospovidone, PVP-CL1 and sodium carboxymethylcellulose, Ac-Di-Sol1 in
the 1:3 active-to-polymer weight ratio. By this process it was assessed that the main
extract components lost its crystalline structure, and the powder surface area was
increased by 2.1- and 1.7-fold in the coground products with Ac-Di-Sol1 and PVP-CL1,
respectively. This activated status of the dry extract remained stable over a period of
2 years. Solubilization kinetics resulted ameliorated both in terms of entire dry extract
and in terms of single components. When the 1/3 coground systems with PVP-CL1 and
Ac-Di-Sol1 were dissolved in saturated conditions they gave a concentration improve-
ment compared to the native product of 8 and 31 times of silybin A, 7 and 27 times of
silybin B, whereas in the case of silychristin a double concentration was obtained only
using Ac-Di-Sol1. The in vivo studies on rats confirmed that this solubilization improve-
ment corresponded to an effective oral bioavailability enhancement. The highest bioa-
vailability improvement was obtained with Ac-Di-Sol1, with a relative bioavailability of
88.6, 17.96, and 16.4 compared to the extract for silybin A, silybine B, and silychristine,
respectively.  2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci
98:215–228, 2009Keywords: Silybum marianum extract; solid state; mechanical activation; micro-
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Silybum marianum L. Gaertn. (milk thistle,
Asteraceae), are used in humans for the treatments dedicated to Professor Fulvio Rubessa, who
from his position as full professor at the
macy, University of Trieste, after more than
nguished academic career.
ce to: D. Voinovich (Telephone:þ39-0405583106;
572; E-mail: vojnovic@units.it)
aceutical Sciences, Vol. 98, 215–228 (2009)
, Inc. and the American Pharmacists Association
JOURNAL OF Pof liver diseases of different etiologies.1 The
interest in the potential benefits of Silybum
marianum originates in antiquity and it is one
of the first documented examples of plants used
for maintenance of health and treatment of
disease.2 The group of active constituents, named
silymarin, mainly consists of silybin (40–60%) and
isosilybin (10–20%; each as pair of diastereoi-
somers A and B), silydianin and silychristin
(20–45%).3
The therapeutic use of these flavonolignans is
partly restricted by their insolubility in water.
In particular, silybin, the main constituent, isHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009 215
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tends to form nonabsorbable microcrystals. The
oral bioavailability of this herbal medicine is
therefore limited and it is strictly dependent on
the galenical preparation, as shown for various
silymarin products on the market.4
Several approaches to improve the oral bioa-
vailability of sylimarin have been attempted: its
complexation with phosphatidylcholine,5,6 the
formation of an inclusion complex with b-cyclo-
dextrins,7 the creation of water-soluble matrices
by spray drying or lyophilizing process,8 solid
dispersions with hydrophilic polymers such as
PEG 60009,10 and, finally, the formulation of a
self-microemulsifying systems.11 With respect to
these previous studies the purpose of the present
research was to ameliorate the solubilization
kinetics of each individual component of this
herbal medicine. In fact, it is well known that the
pharmacological activity of an herbal medicine
depends on the overall activity of a variety of
active compounds and synergistic action of these
components is the basis of herbal recipes. For this
purpose, the cogrinding process in a planetary
mill was applied to increase simultaneously the
in vitro dissolution performance of the main
components of S. marianum extract by their
incorporation in two crosslinked hydrophilic
polymers.
The mechanical stress, given by this mechan-
ochemical process, induces dislocation in the
structures of both active principles and polymer,
with consequent intra-particle embedding of the
active crystallites and further active molecular
dispersion in the carrier.12 Micronized crospovi-
done PVP-CL1 and crosslinked sodium carbox-
ymethylcellulose, Ac-Di-Sol1, were chosen as
polymeric carriers because both of them, through
their different chemical affinity (the first is
amphyphilic and the second is hydrophilic), have
shown a good capability to improve the bioavail-
ability of several poorly soluble drugs.13,14
After preparation of the binary systems, the
effect of the process on the properties of the
dry extract and on the main constituents was
evaluated by studying their in vitro solubilization
kinetics, their solid state and possible interaction
between the components (XRD and DRIFT), their
particle size and surface area in comparison with
the starting raw materials and the simple
physical mixtures (PMs). Finally, the in vivo
oral absorption on rats of the 1:3 w/w active to
Ac-Di-Sol1 and PVP-CL1 coground systems was
tested.JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009MATERIALS AND METHODS
Materials
Silybin A and B, silychristin and S. marianum dry
extract were provided by Indena S.p.A. (Milano,
Italy). Naringenine pure standard was from
Extrasynthese (Genay, France), b-glucuroni-
dase/arylsulfatase (Helix pomatia) was from
Boehringer Mannheim (Mannheim, Germany).
Micronized crospovidone (PVP-CL1 M) was pur-
chased by BASF/Euphar (Milano, Italy) and
crosslinked sodium carboxymethylcellulose (Ac-
Di-Sol1) was provided by Shilling (Milan, Italy).
All other chemicals, of analytical grade, and
solvents HPLC grade, were provided by Carlo
Erba (Milan, Italy).
The chemical structures of tested compounds
are listed in Table 1.Preparation of Coground Mixtures
Dry extract alone and in combination of PVP-CL1
or Ac-Di-Sol1were coground in 1:3 dry extract-to-
polymer weight ratios in a planetary mill Fritsch
P7 (Pulverisette, Contardi Fritsch s.r.l., Milan,
Italy) at 360 rpm (VP; 12 Hz). For comparison
purposes, also the 1:1 dry extract-to-polymer
weight ratio was prepared. The planetary mill
was equipped by four agate cylindrical grinding
chambers with a capacity of 25 mL each contain-
ing 4 agate balls as grinding media, with a
diameter of 12 mm. Fifty grams batches, pre-
viously blend in the suitable proportions with
a stainless steel spatula, were simultaneously
coground. The ball-to-powder mass ratio was 1.25.
The grinding procedure was pursued for 1 h,
stopping every 15 min for homogeneously mixing
the mass with a stainless steel spatula.Preparation of Physical Mixtures
For comparison purposes, PMs were prepared by
manually mixing dry extract and each polymer
using the same weight ratios as the coground
systems.X-Ray Powder Diffraction Studies (XRD)
Solid state of the samples was studied by means of
XRD technique using a STOE D500 (Siemens,
Munich, Germany) diffractometer with Cu-Ka
radiation (1.5418 A˚), monochromatized by aDOI 10.1002/jps
Table 1. Chemical Structure of Carriers and Studied Flavonolignans
Compound Abbreviation Chemical Structure
Crospovidone PVP-CL1
Croscarmellose
sodium Ac-Di-Sol1
Flavonolignans
Silybin A
Silybin B
Silychristin
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009
MECHANOCHEMICAL ACTIVATION OF THE SILYBUM MARIANUM PHYTOCOMPLEX 217
218 VOINOVICH ET AL.secondary flat graphite crystal. The current used
was 20 mA and the voltage 40 kV. The scanning
angle ranged from 58 to 308 of 2u, steps were of
0.058 of 2u, and the counting time was of 2 s/step.DRIFT Spectroscopy
Fourier transform-infrared spectra were obtained
on a FT-IR spectrometer (FT-IR Perkin Elmer
Spectrum One, Monza, Italy) using the diffuse
reflectance method (DRIFT). The samples (dry
extract, carriers and 1:3 (w/w) PM and coground
system) were added to anhydrous KBr (FT-IR
grade) in a 1:15 weight ratio (sample to KBr) and
gently ground, thus avoiding solid transition
possibly induced by extended grinding. The
scanning range was 450–4000 cm1 and the
resolution was 4 cm1, scan number was 8 and
scan speed 0.20 cm/s.Porosity Measurements
The porosity of the samples has been determined
with a mercury porosimeter (ThermoQuest Italia,
Rodano, Italy) equipped by Macropore Pascal 140
low pressure porosimeter and Macropore Pascal
240 high pressure porosimeter (Carlo Erba
Instruments, Milan, Italy). A dilatometer for
powders with capillary diameter of 1.5 mm was
loaded with 300 mg samples. Before measuring, a
degasification procedure under vacuum pressure
for 30 min was performed. The experiments were
performed in triplicate. The volume of mercury
intruded in function of the applied pressure was
transformed in the porous distribution applying
the model of cylindrical porosity of Washburn. The
size distribution was calculated applying the
Mayer and Stowe method,15 whereas the specific
surface area was calculated by using the method
proposed by Rootare and Prenzlow.16Solubilization Kinetics
The solubilization kinetics of the coground sys-
tems was determined in nonsink conditions
according to Nogami et al.17 and compared to
the corresponding PMs. In particular, an excess
quantity of the samples was added to 900 mL of
deionized water in a USP 28 dissolution vessel, at
a temperature of 37.0 0.58 while stirring with a
paddle at 200 rpm. The tested amount for each
sample approximately corresponded to threeJOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009times its solubility in water. Samples (5 mL) were
collected at predetermined time intervals, and
filtered with Sartorius regenerated cellulose mem-
brane 0.45 mm. The dissolved dry extract was
spectrophotometrically determined and absor-
bances were recorded at 287 nm.
Furthermore, the solubilization kinetics of
three main components of the dry extract, silybin
A and B, and silychristin from the coground
systems and the starting extract was singularly
determined, using the same conditions used for
the determination of the entire dry-extract but
quantifying the solubilized amount with a HPLC
technique reported into details in the following
paragraphs.In Vivo Absorption Studies
Experiments on animals complied with the Italian
D.L. n. 116 of 27 January 1992 and associated
guidelines in the European Communities Council
Directive of 24 November 1986 (86/609 ECC).
Animals used were male Sprague–Dawley rats
(250–280 g weight) and were supplied by Centro
Servizi Polivalenti di Ateneo (University of
Trieste). Rats, with free access to water, were
fasted overnight. Experimental formulations were
administered by gastric gavage as aqueous sus-
pensions to four rats. Each rat received a single
dose of formulations: 50 mg/kg of S. marianum dry
extract corresponding to 8.5, 8, and 10.5 mg/kg of
silybin A, silybin B and silychristin, respectively,
and 50 mg/kg of 1:3 w/w coground systems
corresponding to 2.6, 2.25, 4.45 mg/kg of silybin
A, silybin B and silychristin, respectively, as
determined by HPLC.
Blood samples were collected from animal
abdominal aorta in heparinized tubes at 0.5, 1,
2, and 4 h after administration. Blood samples
were centrifuged at 2500 rpm for 15 min and
plasma was separated and immediately frozen at
208C, and stored at this temperature till the
analysis.Sample Preparation
For the determination of the flavolignans in the
coground systems the procedure was the follow-
ing: the suitable amount of dry extract as a powder
or coground mixture was accurately weighted
and transferred to a 25 mL volumetric flask and
diluted with 20 mL of methanol. The mixture was
sonicated for 15 min and then diluted to 25 mLDOI 10.1002/jps
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through a 0.45 mm nylon filter to remove any
particle. The first 5 mL of the filtrates were
discarded and the subsequent were collected.
Appropriate aliquots of filtrates were diluted with
the mobile phase.
As for the determination of total flavolignans,
silybin A and B, silychristin in plasma samples the
following procedure was adopted. One milliliter
serum sample containing the internal standard
naringenin (50 mL of an internal standard
solution containing 2 mg/mL) was incubated with
1 mL of 1 M sodium acetate buffer pH 5.0 and
100 mL of b-glucuronidase/arylsulfatase for 3 h at
378C, while shaking at 55 rpm. After adding 2 mL
of 0.5 M borate buffer solution pH 8.5, the
flavonolignans and the internal standard narin-
genin were extracted into 5.5 mL diethyl ether by
shaking at 55 rpm for 20 min. After centrifugation
for 10 min at 2000g (128C) the organic phase was
transferred into 5 mL micro-reaction vessels and
evaporated at 458C under a stream of nitrogen.
The residue was redissolved in 200 mL of
methanol, vortexed for 1 min, centrifuged and
50 mL of the supernatant were used for HPLC
analysis.Frel ¼ AUCðPVP or Ac-Di-SolÞ=DoseðPVP or Ac-Di-SolÞ
AUCðExtractÞ=DoseðExtractÞ (1)Assay of Active Components by HPLC
Silybin A, B and silychristin were determined by
a previously published HPLC method,18 using a
HPLC systems consisting of a HP 1090L instru-
ment with a Diode array detector and managed by
a HP 9000 workstation (Hewlett Packard, Palo
Alto, CA). The HPLC system was interfaced with a
HP1100 MSD API-electronspray (Hewlett Pack-
ard). The interface geometry, with an orthogonal
position of the nebulizer, with respect to the
capillary inlet, allowed the use of analytical
conditions similar to those of HPLC-DAD analy-
sis. The same column, mobile phase and flow rate
were used. Mass spectrometry operating condi-
tions were optimized to achieve maximum sensi-
tivity values: gas temperature 3508C at 11 L/min,
nebulizer pressure 40 psi, quadrupole tempera-
ture 308C and capillary voltage 3000 V. Full
spectra from m/z 100 to 1000 in negative ion mode
were obtained.DOI 10.1002/jps JOURAs for the chromatographic conditions, the
column was a Hibar RT 250-4.6 Purosphere
STAR RP-18 (5 mm, 250 mm, 4.6 mm id, Merck,
Darmstadt, Germany) maintained at 308C. Chro-
matographic separation was carried out using an
isocratic elution of water (pH 3.2 formic acid) and
methanol (50–50%). The analysis was for a 30 min
period at a flow rate of 1.0 mL/min. Injected
volume of the sample was 20 mL. Ultraviolet
spectra were recorded in the range 200–600 nm
and chromatograms were acquired at 220, 254,
270, 285, and 350 nm.Pharmacokinetic Analysis
Pharmacokinetic parameters were calculated on
the composite plasma curves. The area under the
plasma concentration-time curve extrapolated to
the last sampling time at which a quantifiable
concentration is found (AUClast) was calculated
using the log-linear trapezoidal method. Time and
value of maximum concentration (tmax and Cmax,
respectively) were reported as observed. The
relative bioavailability after oral administration
( Frel) was calculated in Eq. (1):Pharmacokinetic analysis was performed using
WinNonlin Version 2.1 (Pharsight Corporation,
Mountain View, CA) software.RESULTS AND DISCUSSION
As previously stated, the aim of the work was
to increase simultaneously the water solubility
of the components of the phytocomplex by solid
state mechanochemical activation with the use of
hydrophilic crosslinked polymers as carriers and
thus to possibly improve their oral biovailability.
The solid state activation was performed in
a planetary mill that is suitable for generating
predominantly shearing interactions as a result
of the rolling of steel ball elements on the wall of
the grinding container. Briefly, the planetary
mill generates a tangential mechanical strain,
that promotes a plastic deformation of nativeNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009
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dimensions and shape of the particles but also to
the accumulation of defects. Such defects can lead
to nanocrystals and/or amorphization of the drug
particles that get trapped in the amorphous
polymer network. Both these phases represent
an activated status of a drug that has a higher
bioavailability and reduced response times.12
Figure 1 is a schematic representation of possible
interactions between active and each polymer.Figure 1. Schematic representation of the composite
structure and possible interaction between the flavono-
lignans and Ac-Di-Sol1 (a) or PVP-CL1 (b).
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009First of all, the extract alone was processed in
the planetary mixer. However nonsatisfactory
results were obtained. In fact the powder during
the process adhered to the chamber walls and to
the grinding balls forming a very hard layer, thus
inhibiting the mechanochemical process itself.
This inconvenient did not occur when the extract
was diluted with the carriers. For this reason,
all the subsequent trials were only conducted
on binary mixtures. Simple PMs, prepared by
manually mixing active and each polymer, were
used as a matter of comparison of the coground
systems.
To check possible solid state variations of
the dry extract, XRD analysis was carried out.
Figure 2 reports the diffractograms of the raw
materials: the two carriers, PVP-CL1 and Ac-Di-
Sol1, S. marianum dry extract and its major
active components, silybin A and B.
Both polymeric carriers show a complete lack of
peaks and a halo pattern, typical of amorphous
materials. In the pattern of PVP-CL1 (Fig. 2c) two
consecutive broad bands are evident in the range
between 78 and 258 of 2u; whereas only one hump
is visible in the Ac-Di-Sol1 pattern (Fig. 2d)
between 178 and 238 of 2u.
Conversely, the diffraction pattern of silybin
AþB (Fig. 2a) shows several very intense peaks,
indicating the crystalline structure of the mate-
rial. In particular, the highest signals are evident
at 14.68, 16.58, 19.58, 22.38, and 24.58 of 2u.
The dry extract behaves at the XRD analysis
as a semi-crystalline material, showing some
peaks of medium intensity together with a strong
underneath scattering phenomenon, due to its
amorphous content (Fig. 2b). As for the crystallineFigure 2. XRD patterns of the raw materials: silybin
AþB (a), Silybum marianum dry extract (b), PVP-CL1
(c), and Ac-Di-Sol1 (d).
DOI 10.1002/jps
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reflections of the extract major components,
silybine AþB, are also present in the diffracto-
gram of the dry extract with only a little upward
shift phenomenon. Furthermore, the absence of
signals different from those of silybin A and B in
the diffractogram of the dry extract demonstrates
that the other components are of amorphous
nature or not detectable due to their little content
in the extract. For example, the weight percentage
of silydianin in the dry extract is about 6%, that is
quite near to the sensitivity of this analytical
method.19 It can be concluded that the detectable
crystalline component of the extract is almost
totally represented by silybine A and B.
In Figure 3 the diffractograms of the dry
extract/PVP-CL1 binary systems are presented
and compared to the single components. The XRD
patterns of the coground systems of the 1:1 and 1:3
active to polymer weight ratios are almost super-
imposable (Fig. 3c and d, respectively). Both of
them are typical of completely amorphous materi-
als, with a lack of peaks and an evident scattering
phenomenon. Two large humps can be recognized:
the first one, at about 128 of 2u, probably
attributable to the polymer that shows his apex
at this angle (see Fig. 3e), and the second one, with
a maximum at about 228 2u, probably due to the
transition into an amorphous state of the dry
extract, that reveals in its semicrystalline original
form its major peaks in this range. This fact is
more significant when considering the 1:1 w/w
coground system (prepared only for comparison
purposes), where the absence of signals cannot beFigure 3. XRD patterns of the binary mixtures with
PVP-CL1: 1:3 w/w PM (b), 1:1 w/w coground system (c)
and 1:3 w/w coground system (d), compared to pure
Silybum marianum dry extract (a) and pure PVP-
CL1 (e).
DOI 10.1002/jps JOURascribed to the low content of silybin AþB (that
actually represents about 16.5% w/w of the
mixture) but to the amorphization of the crystal-
line component. To check whether this phenom-
enon is due to the presence of the polymer or to
the mechanochemical activation process, the XRD
patterns of the coground systems were compared
to those of the corresponding PMs, containing
the same dry extract to polymer weight ratio as the
coground systems. For the sake of brevity, only the
1:3 w/w PM is depicted in Figure 3b. This pattern
still shows a certain degree of residual crystal-
linity of silybine AþB as indicated by the peaks in
its typical angles (e.g., 14.68, 16.58, 19.58, 22.38,
and 24.58of 2u), in contrast to the corresponding
coground system. This means that the mechano-
chemical activation is responsible for the achieve-
ment of a dry extract of amorphous character in all
his components. Moreover, the energetic contri-
bution given by the mechanochemical activation,
favors the interaction between dry extract amor-
phous components and the polymeric carrier.
Moreover, this interaction results in the stabiliza-
tion of the highly reactive amorphous state. In
fact, repeating the XRD analysis on aging, the
amorphous character of the 1:3 w/w coground
systems with PVP-CL1was maintained also after
2 years (Fig. 4a).
In Figure 5 the diffractograms of the dry
extract/Ac-Di-Sol1 binary systems are presented
and compared to the single components. Also in
this case, the XRD patterns of the 1:1 and 1:3 w/w
coground systems are almost superimposable
(Fig. 5c and d), both showing a strong scatteringFigure 4. XRD patterns of the 1:3 w/w coground
systems with Ac-Di-Sol (b), and PVP-CL1 (a) after
2 years of ageing.
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Figure 6. DRIFT spectra of the –OH stretching and
carbonyl stretching region: 1:3 (w/w) coground system
(a), corresponding PM (b), Ac-Di-Sol1 (c), the dry
extract (d).
Figure 7. DRIFT spectra of the –OH stretching
and carbonyl stretching region: 1:3 (w/w) coground
system (a), corresponding PM (b), PVP-CL1 (c), the
dry extract (d).
Figure 5. XRD patterns of the binary mixtures with
Ac-Di-Sol1:1:3 w/w PM (b), 1:1 w/w coground system
(c), and 1:3 w/w coground system (d), compared to
pure Silybum marianum dry extract (a) and pure
Ac-Di-Sol1 (e).
222 VOINOVICH ET AL.phenomenon and a band in correspondence of the
apex of the polymer. In the 1:3 w/w PM (Fig. 5b),
in addition to the band of Ac-Di-Sol1, a reduced
scattering phenomenon can be noticed together
with some signals of low intensity, in correspon-
dence to the most intense signals of the dry extract
(14.58, 17.58, 22.58, and 24.58 of 2u). Also in this
case the XRD analysis was repeated on aging
on the 1:3 w/w coground systems, attesting the
absence of crystalline lattice after 2 years from the
preparation (Fig. 4b). This means that cogrinding
the dry extract with both PVP-CL1 and Ac-Di-
Sol1, in 1:1 and 1:3 weight ratios, a completely
amorphous and stable product is obtained.
It is well known that vibrational changes can
serve as probes of intermolecular interactions in
solid materials. Amongst the different IR techni-
ques DRIFT is the best choice because minimal
sample manipulation is required,20 and for this
reason it has been employed to verify previous
interactions hypotheses. The possible interaction
would occur between the –OH, C––O, and –O–
groups of flavonolignans,21,22 and –OH, –O–C––O,
C––O, –O– groups of Ac-Di-Sol
123,24 or C––O and –
NH of PVP-CL1.25,26 Any interaction would be
reflected by shifts in the vibrations of these
groups.
In Figures 6 and 7 the DRIFT spectra of the –
OH stretching and carbonyl stretching region are
reported: in particular each figure compares the
features of 1:3 (w/w) coground system (a),
corresponding PM (b), each carrier (c), the dry
extract (d).JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009In agreement with previous physical character-
izations, this analysis reveals that the PM with
Ac-Di-Sol (Fig. 6) can be simply regarded as the
superimposition of those of dry extract and carrier
in the whole spectrum, suggesting the absence of
significant chemical interactions, whilst in the
coground system some peaks are missing and
others are remarkably decreased. In particular,
the band at 3608 cm1 assigned to the free –OH,
the band at 3458 cm1 and the shoulder at
3175 cm1, attributable to the –OH intermolecu-
lar association21 are still present in the PM. OnDOI 10.1002/jps
Figure 8. Cumulative size distribution of the parti-
cles the binary mixtures with Ac-Di-Sol1: 1:3 w/w PM
(&), 1:3 w/w coground system (^) (a); differential plot of
the particle size in the 1:3 w/w PM (curve A) and
coground system with Ac-Di-Sol1 (curve B) (b).
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coground system and replaced by a unique broad
band. As for the carbonyl stretching region, the
PM substantially corresponded to the super-
imposition of the peaks of the 2 components;
whereas in the coground no difference was
observed in the position of the bands, but the
percentage absorption of the 1635 cm1 peak is
remarkably reduced while that of 1595 cm1
is increased; further the peak at 1525 cm1 is
absent. It seems that when the dry extract is
coground with Ac-Di-Sol1, the hydrogen bonding
is decreased but no indication of interaction
between drug and carrier was observed.
As for the PVP-CL1 systems (Fig. 7) the band at
3608 cm1 and at 3458 cm1 and the shoulder at
3175 cm1 are completely absent in the coground
system, whilst in the PM only but one peak is
recognizable: modest and shifted at 3463 cm1.
Looking at the carbonyl stretching region, it can
be noticed that the band most likely assigned
to the vibration of the C––O of the polymer
25
remarkably shifted from 1678 cm1 toward
lower frequencies (to 1670 cm1 in the PM and
1657 cm1 in the coground). All these facts
suggest the existence of moderate interactions,
probably consisting in hydrogen bonding, in the
PM and severe in the coground system between
the flavonolignans and PVP-CL1. This is not
surprising since it is known that PVP-CL1 which
is effective in binding polyphenols.26,27
An additional important information that can
be get from the spectra of the coground systems is
the confirmation of the disruption of the crystal
lattice after mechanochemical activation. In fact,
the splitting phenomenon between 1525 and
1505 cm1, typical feature of a crystal lattice in
the correlation field, is present in the active, is still
present in the PMs but is absent in both coground
systems, where is replaced by a unique peak at
about 1509 cm1 (see circles in Figs. 6 and 7).
The next step was to study the influence of the
mechanochemical process on the particle size and
the specific surface area of the produced particles.
In Figure 6a the oversize cumulative distribution
of the 1:3 w/w coground systems with Ac-Di-Sol1
are depicted and compared to the simple PMs.
The 1:3 w/w coground system shows in all the
dimensional range a remarkable reduction of
the particle size with respect to the untreated
mixture of powders (Fig. 8a). When plotting the
volume percentage as a function of the diameter
(Fig. 8b), it appears that the distribution is
bimodal for both coground and PM, with theDOI 10.1002/jps JOURfirst narrow curve in the 2–22 mm size range and
the second broad curve representing the larger
particles with a diameter between 22 and 100 mm.
After mechanochemical activation a dramatic
reduction of the frequency of the particles having
dimensions between 22 and 100 mm is attested
(curve B). As showed in Table 2, this particle size
reduction corresponds to a remarkable increase
(210%) of the specific surface area with respect to
the simple PM. In the case of the 1:3 w/w binary
systems with PVP-CL1 (Fig. 9), a different effect
of the cogrinding process was noticed: the
cumulative oversize distribution (Fig. 9a) showed
a increase of the percentage of particles smaller
than 10 mm and a diminution of the percentage of
particles with superior size. Looking at the dif-
ferential plot of the particle size of the same
samples (Fig. 9b) the following features can be
noticed: in both diagrams a sharp peak followed by
a large broad band is showed, attesting a bimodal
distribution of particle size. Observing the first
peak, representing the fines, it can be noticed that
the size dimension is reduced after cogrindingNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009
Table 2. Specific Surface Area Calculated by the Hg Porosimetry Analysis
Sample Specific Surface Area (m2/g)
1:3 w/w dry extract/Ac-Di-Sol1 PM 0.77
1:3 w/w dry extract/Ac-Di-Sol1 coground system 1.62
1:3 w/w dry extract/PVP-CL1 PM 0.83
1:3 w/w dry extract/PVP-CL1 coground system 1.41
224 VOINOVICH ET AL.(curve B) and its percentage is higher than in the
PM (curve A). As for the large particles, expressed
by the second broad band, in the PM they had a
maximum at about 50mm and were not superior to
270 mm whilst in the coground system the band
is broader since the particles were comprised
between 50 and 400 mm with a maximum ranging
about 120 mm. The overall result is a widening of
the particles size distribution: some particles are
reduced while some are increased, resulting in an
increase of fines and a presence of large particles
of different sizes, including a little percentage of
large agglomerates superior to 270 mm. While the
reduction of particles diameter is easily predict-
able after cogrinding, the presence of largeFigure 9. Cumulative size distribution of the parti-
cles the binary mixtures with PVP-CL1: 1:3 w/w PM
(&), 1:3 w/w coground system (^) (a); differential plot of
the particle size in the 1:3 PM (curve A) and coground
system with PVP-CL1 (curve B) (b).
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009agglomerate is not common but it is anyway not
totally new, especially when using crospovidone.
In fact a similar undesired particle growth was
noticed in some previous mechanochemical acti-
vation experiences,28 when large and hard
agglomerates were obtained. These authors have
found that the phenomenon can be related to
formulation variables, such as the polymeric
material, the drug-carrier combination but also
to process variables, for example, the type of
vibrational mill, the grinding time, the frequency
used. Since in this case the process variables were
kept constant for the preparation of the samples,
the formulation variables seem to play a prevalent
role in this phenomenon: in particular the
presence of crospovidone and the nonnegligible
quantity of water trapped in its matrix may
be responsible for the formation of large agglom-
erates, with a mechanism probably similar to a
wet granulation process.
It should be noticed that the finding of the large
agglomerates cannot be an artifact of the analysis
conditions, since it is well known that the mercury
porosimeter, in contrast to other particle size
analyzers, permits to overcome problems related
to the undesired aggregation of the sample,
through an appropriate study of the hysteresis
in the Hg intrusion–extrusion curve of the
considered sample.29
Despite the results of particle size distribution,
a pronounced increase of the specific surface area
of the coground systems with crospovidone was
noticed with respect to the PM: the surface area of
the coground product is about twice than that of
the PM, as reported in Table 2, testifying that the
cogrinding procedure lead to a system theoreti-
cally more prone to the dissolution.
The subsequent step consisted in the evaluation
of the in vitro dissolution performances of the
coground systems using the solubilization kinetics
method in comparison to the PMs and to the
starting dry extract. Within this aim, on the one
hand the release of the entire dry extract was
analyzed, and on the other hand the release ofDOI 10.1002/jps
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A and B, and silychristin, all together represent-
ing about the 54% of flavolignans) was singularly
tested determining the solubilized amount of each
component.
As reported in Figure 10, the better perfor-
mance of both coground systems compared to the
dry extract is evident, both in terms of rate and
extent of dissolution, testifying the mechano-
chemical process led to an activated status easier
to be dissolved, thanks to the increased specific
surface area and to the absence of crystalline
lattice in the active components.
Amongst the samples, the best profile can be
achieved with the 1:3 w/w coground with Ac-Di-
Sol1, being able to maintain the highest solubi-
lized amount of active (81.30 mg/mL) for the entire
duration of the analysis. In the case of the PVP-
CL1 a supersaturation phenomenon was noticed
after 3 min from the beginning of the test, that led
to a little decrease of the components concentra-
tions. After that the solubilized amount of actives
is kept almost stable at about 63 mg/mL, thanks to
the presence of the remarkable chemical interac-
tions between PVP and dry extract components.
As a confirmation that the mechanochemical
process positively influences the solubilization
kinetics of the flavonolignans, a very different
behavior was observed with the PMs, where no
solubilization improvement was attested. As
expected, the PM containing Ac-Di-Sol1, simply
consisting of a mixture of the components without
any significant interaction, displayed a solubiliza-
tion kinetics not very different from that of theFigure 10. Solubilization kinetics of the entire dry
extract in 1:3 w/w coground system with Ac-Di-Sol (a),
1:3 w/w coground system with PVP-CL1 (b), pure Sily-
bum marianum dry extract (c), 1:3 w/w PM with Ac-Di-
Sol1 (d), 1:3 w/w PM with PVP-CL1 (e).
DOI 10.1002/jps JOURpure dry extract. Conversely, in the case of the PM
with PVP-CL1, where modest chemical interac-
tions have been found by DRIFT analysis, in
accordance to literature data,26,30 a release profile
inferior to the native extract was obtained.
As for the release of the single components
of the dry extract, the profiles are shown in
Figure 11.
The dissolutions of both silybin A and silybin B
resulted to be dramatically enhanced when
coground in presence of PVP-CL1 and Ac-Di-
Sol1. The release of silybin A and B from the
coground systems with crospovidone led respec-
tively to eight- and sevenfold higher concentration
level compared to the native extract. Once again a
supersaturation phenomenon could be noticed
after 5 min from the beginning of the test. After
about 30 min of release, the concentration of
the active components tended to increase again
probably because at this time the complete
disintegration of the above-mentioned large aggre-
gates was reached and hence the dissolution
process was boosted.
Analogously, the highest solubility value at
the equilibrium was reached from the coground
system prepared with Ac-Di-Sol1 obtaining a
concentration increase of about 31- and 27-fold for
silybin A and B, respectively.
As for the third active component, silychristin,
the presence of Ac-Di-Sol1 doubled its releaseFigure 11. Solubilization kinetics of the single com-
ponents of the dry extract: Silybin B (~) and Silybin A
(&) in 1:3 w/w coground system with Ac-Di-Sol1, Sily-
bin B (~) and Silybin A (&) in the 1:3 w/w coground
system with PVP-CL1, Silybin B (*) and Silybin A (*)
in pure Silybum marianum dry extract, Silychristin in
1:3 w/w coground system with Ac-Di-Sol1 (^) and in
the pure Silybum marianum dry extract (^).
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226 VOINOVICH ET AL.with respect to the dry extract. Conversely, the
concentration of silychristin released from PVP-
CL1was too little and not sufficient to be detected
by HPLC, probably due to the above mentioned
chemical interactions. Since the solid state of
silychristin is unchanged after cogrinding with
Ac-Di-Sol1, its solubilization enhancement seems
to be attributable to the favorable presence of the
hydrophilic carrier and to the increased surface
area after mechanochemical process.
As a completion of this research, the in vivo
bioavailability of the main S. marianum compo-
nents after oral administration in rats of the two
coground systems was assessed in comparison
with the pure dry extract. In Figure 12 the plasma
concentration profiles are presented whilst the
pharmacokinetic parameters are listed in Table 3.
As regards to silybine A, a remarkable increase
of its bioavailability after mechanochemical acti-
vation with both crosslinked polymer was
obtained with respect to the pure dry-extract. In
particular, Ac-Di-Sol1 and PVP-CL1 led to an
oral relative bioavailability with respect to the
extract of 88.6 and 34.5, respectively. Whereas for
silybine B, its bioavailability was 17.96- and 12.1-
fold higher than that associated with intake of the
dry extract, when using Ac-Di-Sol1 and PVP-
CL1, respectively. The relative bioavailability
of silychristine with Ac-Di-Sol1 obtained an
increase of 16.4-fold. As for the coground system
with PVP-CL1, analogously to the behavior
noticed during the in vitro analyses, the chemical
interactions are responsible for the lack of an
appropriate release of the active compound from
the composite. From this experimental evidence,
the improvement of the bioavailability of all tested
flavolignans is higher when using as a carrier
Ac-Di-Sol1.Figure 12. Mean plasma levels of the main flavo-
lignans of Silybum marianum, obtained after single
oral dose (50 mg/kg): (a) silybin A in 1:3 w/w coground
system with Ac-Di-Sol1 (&), with PVP-CL1 (&), and in
Silybum marianum dry extract (*); (b) silybin B in
1:3 w/w coground system with Ac-Di-Sol1 (~), with
PVP-CL1 (~), and in Silybum marianum dry extract
(*); (c) silychristin in 1:3 w/w coground system with
Ac-Di-Sol1 (^) and in the Silybum marianum dry
extract (^).CONCLUSIONS
The main components of S. marianum dry
extract were all contemporarily activated through
the mechanochemical activation with polymeric
crosslinked carriers, PVP-CL1 and Ac-Di-Sol1.
The activation was confirmed by the structural
change of main crystalline components, the
change in the size and surface area of the powders
and by the release performances of each single
component in water. This activated status
remained stable over a period of 2 years.
As a confirmation that the mechanochemical
process positively influences the solubilizationJOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 1, JANUARY 2009 DOI 10.1002/jps
Table 3. Pharmacokinetic Parameters Relative to Main Components of Silybum marianum after Oral
Administration in Rats of the Dry Extract and Coground Systems
Silybine A Silybine B Silychristine
Extract PVP-CL1 Ac-Di-Sol1 Extract PVP-CL1 Ac-Di-Sol1 Extract Ac-Di-Sol1
Dose (mg/kg) 8.5 2.6 2.6 8 2.25 2.25 10.5 4.45
tmax (h) 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00
Cmax (mg/mL) 0.93 3.00 7.66 1.67 4.43 7.69 0.63 1.85
AUClast (hmg/mL) 0.63 6.70 17.20 3.79 12.90 19.15 0.72 5.02
Dose-normalized parameters
Cmax (mg/mL) 0.11 1.15 2.95 0.21 1.97 3.42 0.06 0.42
AUClast (hmg/mL) 0.07 2.58 6.61 0.47 5.73 8.51 0.07 1.13
Frel (PVP-CL
1 or
Ac-Di-Sol1 vs. Extract)
1 34.5 88.6 1 12.1 17.96 1 16.4
MECHANOCHEMICAL ACTIVATION OF THE SILYBUM MARIANUM PHYTOCOMPLEX 227kinetics of the flavonolignans, a very different
behavior was observed with the PMs, where no
solubilization improvement was attested. The
solubilization kinetics resulted ameliorated both
in terms of entire dry extract and in terms of
single components, in comparison to the PMs and
to the pure extract, achieving the best in vitro
profile with the 1:3 w/w coground with Ac-Di-
Sol1. These findings were confirmed by the in vivo
absorption studies in rats that revealed a very
remarkable improvement of the bioavailability of
all the tested flavolignans when coground with
Ac-Di-Sol1.
It can be concluded that the solid state
mechanochemical process is a viable means to
increase the in vitro solubilization of various
active components and therefore to improve their
bioavailability when given by oral route.ACKNOWLEDGMENTS
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